{"doi":"10.4155/fmc-2021-0111","title":"Targeting Mucin Hypersecretion in COVID-19 Therapy","abstract":null,"journal":"Future Medicinal Chemistry","year":2022,"id":615131,"datarank":0.26876392038420827,"base_score":1.791759469228055,"endowment":1.791759469228055,"self_citation_contribution":0.26876392038420827,"citation_network_contribution":0.0,"self_endowment_contribution":0.26876392038420827,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":5,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1585337,"name":"Mousmee Sharma","orcid":"0000-0002-7728-5054","position":1,"is_corresponding":false},{"id":1585336,"name":"Parteek Prasher","orcid":"0000-0002-9412-9424","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Targeting Mucin Hypersecretion in COVID-19 Therapy","abstract":null,"is_dataset_classified":null,"base_score":1.6094379124341003,"endowment":1.6094379124341003,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"35315705","pmcid":"PMC8939459","openalex_id":"https://openalex.org/W4220984187","authors":[],"funders":[],"total_grants":0,"fwci":0.5445,"citation_percentile":0.63473668,"influential_citations":0,"citation_trend":[{"year":2022,"count":2},{"year":2024,"count":2}],"oa_status":"green","license":"cc-by","oa_locations":[{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8939459","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8939459","host_type":"repository"},{"url":"https://www.tandfonline.com/doi/pdf/10.4155/fmc-2021-0111","host_type":"publisher"},{"url":"https://doi.org/10.4155/fmc-2021-0111","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/35315705","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC8939459","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC8939459?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["Inhalation and Respiratory Drug Delivery","Pneumonia and Respiratory Infections","SARS-CoV-2 and COVID-19 Research","Humans","Mucins","SARS-CoV-2","COVID-19 Drug Treatment"],"mesh_terms":["SARS-CoV-2","COVID-19 Drug Treatment","Humans","Mucins"],"keywords":["Mucin","Cytokine storm","Lactoferrin","Chemistry","Microbiology","Coronavirus disease 2019 (COVID-19)","Biology","Virology","Medicine","Biochemistry","Pathology","Infectious disease (medical specialty)","Disease","mucins","Covid-19","Sars-cov-2"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[{"name":"doi"}],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-02T19:04:11.586086Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}